The DES Center

Filter Your Results

 

News

 

Pooled Analysis of CREDIT Trials Investigate JW Medical's Excel 2 DES

January 31, 2017 -- Geng Wang, MD, et al published a pooled analysis of the CREDIT II and CREDIT III trials evaluating the efficacy and safety of Excel 2, a second-generation,…

Final EXCELLA II Results Published for Elixir Medical's DESyne Stent Systems

January 9, 2017 -- Javaid Iqbal, MRCP, PhD, et al reported the final 5-year outcomes from the EXCELLA II trial online ahead of print in a href="https://www.pcronline.com/euroi…

BIONICS Data Will Support Medinol's EluNIR DES Submission for FDA Approval

December 21, 2016 -- Medinol announced that the 12-month clinical results from the BIONICS study will be submitted to the US Food and Drug Administration to support regulatory…

Meta-Analysis Evaluates PCI With DES Versus CABG in Unprotected Left Main CAD

December 5, 2016 -- Nitesh Nerlaker, MD, et al assessed whether percutaneous coronary intervention (PCI) using drug-eluting stents is as safe and effective as coronary artery …

OrbusNeich Launches Combo Plus Dual-Therapy Stent

November 29, 2016 -- OrbusNeich recently announced the launch of Combo Plus, the company's latest-generation dual-therapy stent (DTS). The Combo Plus DTS features ant…

Medinol’s JNIR Study of EluNIR DES Approved in Japan

November 7, 2016 -- Medinol, Ltd. announced the receipt of a Clinical Trial Notification from Japan’s Pharmaceutical and Medical Devices Agency to initiate its…

Abbott Vascular's Absorb Bioresorbable Vascular Scaffold Approved in Japan

November 7, 2016 -- Abbott Vascular announced Japan’s Ministry of Health, Labor, and Welfare has approved the company’s Absorb bioresorbable coronary stent. Sold c…

Five-Year DESSOLVE Data Presented for Micell Technologies’ MiStent

November 7, 2016 -- Micell Technologies, Inc. announced 5-year clinical safety and efficacy results from the DESSOLVE I and DESSOLVE II trials of the company’s MiSt…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.